Abstract Deadline Extended for CBS/CSPS/CC-CRS Conference
0 comments
by
Dear members and friends of the Canadian Biomaterials Society, The abstract deadline has been extended to March 2nd, 2026 for the upcoming CBS CCPS cc-CRS 2026 meeting this June in Vancouver, BC...
Dear friends , For this years annual meeting in beautiful Vancouver, BC June 2 - 5 2026 we are happy to partner with the Canadian Society for Pharmaceutical Sciences CSPS and the Canadian Chapter of the Controlled Release Society cc-CRS ...
Call for Abstracts for CBS/CSPS/cc-CRS Conference is now open!
0 comments
by
Call for Abstracts is OPEN The Canadian Biomaterials Society CBS , the Canadian Society for Pharmaceutical Sciences CSPS , and the Controlled Release Society cc-CRS are joining forces to host a landmark joint conference at UBC Vancouver...
Save the Date for CBS2026! June 2–5, 2026
0 comments
by
Overview The Canadian Biomaterials Society CBS , the Canadian Society for Pharmaceutical Sciences CSPS , and the Controlled Release Society cc-CRS are joining forces to host a landmark joint conference at UBC Vancouver...
Bone formation progresses through the steps of collagen matrix production and intrafibrillar crystal formation to create a mineralized extracellular matrix...
Insufficient surface endothelialization of vascular substitutes such as stents and vascular grafts is a main contributor to post-implantation device failure...
Mitigating the Non-specific Uptake of Immunomagnetic Microparticles Enables the Reproducible Isolation of Microvascular Endothelial Cells from Human Adipose Tissue in Large Quantities with High Purity
comments
Continuous subcutaneous insulin infusion CSII is a treatment strategy for Type I diabetes mellitus T1D that relies on insulin infusion sets IIS to deliver insulin to the subcutaneous tissue via a polytetrafluoroethylene PTFE or stainless-steel cannula...
The development of biomaterials and engineered tissues are reshaping the future of medicine. Soft and injectable materials are increasingly used to treat pathologies, release drugs and or seed cells for tissue engineering...
